Equatrate en es it fr

Equatrate Brand names, Equatrate Analogs

Equatrate Brand Names Mixture

  • No information avaliable

Equatrate Chemical_Formula


Equatrate RX_link

No information avaliable

Equatrate fda sheet

Equatrate msds (material safety sheet)

Equatrate Synthesis Reference

No information avaliable

Equatrate Molecular Weight

309.469 g/mol

Equatrate Melting Point

< 25 oC

Equatrate H2O Solubility

Soluble as HCl salt

Equatrate State


Equatrate LogP


Equatrate Dosage Forms

Tablets (oral, 1 mg)

Equatrate Indication

Used for the symptomatic treatment of parkinsonism.

Equatrate Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Equatrate Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Equatrate side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Equatrate Patient Information

Equatrate Organisms Affected

Humans and other mammals